
               
               
               7 DRUG INTERACTIONS
               
               
                  
                     
                        
                           Oral medications may not be absorbed when administered while taking MoviPrep (7).
                        
                     
                  
               
               
                  
                     
                     
                     7.1 Drugs That May Increase Risks Due to Fluid and Electrolyte Abnormalities
                     
                        Use caution when prescribing MoviPrep for patients with conditions, or who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities.Â  Consider additional patient evaluations as appropriate. [See WARNINGS (5)]
                        
                     
                     
                  
               
               
                  
                     
                     
                     7.2 Potential for Altered Drug Absorption
                     
                        Oral medication administered within 1 hour of the start of administration of MoviPrep may be flushed from the gastrointestinal tract and the medication may not be absorbed.
                     
                     
                  
               
            
         